Exacerbation of pemphigus foliaceus after tetanus vaccination accompanied by synthesis of auto-antibodies against paraneoplastic pemphigus antigens [13]

Acta Dermato-Venereologica

Volumn 82, Issue 6, 2002, Pages 482-483

  Korang, Karsten ^d   Ghohestani, Reza ^d   Krieg, Thomas ^d   Uitto, Jouni ^d   Hunzelmann, Nicolas ^a,b,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c SAINT LOUIS HOSPITAL   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; BULLOUS PEMPHIGOID ANTIGEN; CYCLOSPORIN; DESMOGLEIN 1; DESMOGLEIN 3; DESMOPLAKIN; ENVOPLAKIN; IMMUNOGLOBULIN; PERIPLAKIN; PLECTIN; PREDNISOLONE; STEROID; TETANUS TOXOID; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LETTER; PARANEOPLASTIC SYNDROME; PEMPHIGUS FOLIACEUS; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN FAMILY; SERODIAGNOSIS; STEROID THERAPY; TETANUS PROPHYLAXIS; TREATMENT FAILURE;

AUTOANTIBODIES; CADHERINS; CYTOSKELETAL PROTEINS; DESMOGLEIN 1; DESMOPLAKINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; PEMPHIGUS; TETANUS TOXOID; VACCINATION;

EID: 12244274963     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155502762064755     Document Type: Letter

References (9)

1. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by the antidesmoglein autoantibody profile. J Am Acad Dermatol 1999; 40: 167-170.
2. Amagai M, Nishikawa T, Noussari HC, Anhalt GH, Hashimoto T. Antibodies against desmoglein3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998; 102: 775-782.
3. Aho S, Mahoney M, Uitto J. Plectin serves as an autoantigen in paraneoplastic pemphigus. J Invest Dermatol 1999; 113: 422-423.
4. Arteaga LA, Prisayanh PS, Warren SJP, Liu Z, Diaz LA, Lin MS. A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3. J Invest Dermatol 2002; 118: 806-811.
5. Harman KE, Gratian MJ, Shirlaw PJ, Bhogal BS, Challacombe SJ, Black MM. The transition of pemphigus vulgaris into pemphigus foliaceus: a reflection of changing desmoglein 1 and 3 autoantibody levels in pemphigus vulgaris. Br J Dermatol 2002; 146: 684-687.
6. Ishij K, Amagai M, Ohata Y, et al. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay. J Am Acad Dermatol 2000; 42: 859-861.
7. Kazerounian S, Mahoney M, Uitto J, Aho S. Envoplakin and periplakin, the paraneoplastic pemphigus antigens, are also recognized by pemphigus foliaceus autoantibodies. J Invest Dermatol 2000; 115: 505-507.
8. Hashimoto T, Watanabe K, Ishiko A, Shimizu H, Hanyaku H, Kimura S, et al. A case of bullous pemphigoid with antidesmoplakin autoantibodies. Br J Dermatol 1994; 131: 694-699.
9. Foedinger D, Sterniczky B, Elbe A, Anhalt G, Wolff K, Rappersberger K. Autoantibodies against desmoplakin I and II define a subset of patients with erythema multiforme major. J Invest Dermatol 1996; 106: 1012-1016.